Over the last few years, artificial intelligence (AI) has emerged as a disruptive technology and is slowly changing almost every aspect of human life, including the healthcare sector and now, it’s ...

Learn about Rhythm Pharmaceuticals' FDA-approved drug IMCIVREE for obesity, including its potential expansion to children and ...

Since then, law enforcement agencies have approved 17,162 concealed carry permits on Long Island. Data shows less than 3% of ...

Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

In the past 60 days, estimates for Krystal Biotech’s 2024 EPS have increased from $2.09 to $2.38. The consensus estimate for 2025 earnings has improved from $4.33 to $7.31. Year to date, shares of ...

Researchers introduce magnetic soft robots for precision drug delivery, offering programmable control of multiple medications ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...